|
ITCI
|
Intra-Cellular Therapies Inc.
|
0.00%
|
US
|
NASDAQ
|
|
INVA
|
Innoviva, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
INTC
|
Intel Corporation
|
0.00%
|
US
|
NASDAQ
|
|
INBX
|
Inhibrx, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
ICPT
|
Intercept Pharmaceuticals, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
ICAD
|
icad inc.
|
0.00%
|
US
|
NASDAQ
|
|
HYFM
|
Hydrofarm Holdings Group, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
HRMY
|
Harmony Biosciences Holdings, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
GOSS
|
Gossamer Bio, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
GERN
|
Geron Corporation
|
0.00%
|
US
|
NASDAQ
|
|
FOUR
|
Shift4 Payments, Inc.
|
0.00%
|
US
|
NYSE
|
|
FGEN
|
FibroGen, Inc
|
0.00%
|
US
|
NASDAQ
|
|
FFIV
|
F5 Networks, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
ETNB
|
89bio, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
ERAS
|
Erasca, Inc
|
0.00%
|
US
|
NASDAQ
|
|
ENTA
|
Enanta Pharmaceuticals, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
ELAN
|
Elanco Animal Health Incorporated
|
0.00%
|
US
|
NYSE
|
|
EDIT
|
Editas Medicine, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
DSGN
|
Design Therapeutics, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
DAWN
|
Day One Biopharmaceuticals, Inc.
|
0.00%
|
US
|
NASDAQ
|